Regen BioPharma (OTCMKTS:RGBP) Stock is In News: What to Expect Now?
Regen BioPharma (OTCMKTS:RGBP) jumped 18%. The company said that at the end of September 2019, they had cash of around $7,885, but as of September 30, 2020, the company had 0 cash. The reduction is mainly a result of funds spent in the company’s nosiness operations. At the end of September 2020, accounts receivables were around $103,192 relative to $71,186 the year before. The increase resulted from total royalties and…